Unknown

Dataset Information

0

Staphylococcus aureus bloodstream infections in Latin America: results of a multinational prospective cohort study.


ABSTRACT: Background:Substantial heterogeneity in the epidemiology and management of Staphylococcus aureus bacteraemia (SAB) occurs in Latin America. We conducted a prospective cohort study in 24 hospitals from nine Latin American countries. Objectives:To assess the clinical impact of SAB in Latin America. Patients and methods:We evaluated differences in the 30?day attributable mortality among patients with SAB due to MRSA compared with MSSA involving 84?days of follow-up. Adjusted relative risks were calculated using a generalized linear model. Results:A total of 1030 patients were included. MRSA accounted for 44.7% of cases with a heterogeneous geographical distribution. MRSA infection was associated with higher 30?day attributable mortality [25% (78 of 312) versus 13.2% (48 of 363), adjusted RR: 1.94, 95% CI: 1.38-2.73, P?

SUBMITTER: Seas C 

PROVIDER: S-EPMC5890709 | biostudies-literature | 2018 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Staphylococcus aureus bloodstream infections in Latin America: results of a multinational prospective cohort study.

Seas Carlos C   Garcia Coralith C   Salles Mauro J MJ   Labarca Jaime J   Luna Carlos C   Alvarez-Moreno Carlos C   Mejía-Villatoro Carlos C   Zurita Jeannete J   Guzmán-Blanco Manuel M   Rodríguez-Noriega Eduardo E   Reyes Jinnethe J   Arias Cesar A CA   Carcamo Cesar C   Gotuzzo Eduardo E  

The Journal of antimicrobial chemotherapy 20180101 1


<h4>Background</h4>Substantial heterogeneity in the epidemiology and management of Staphylococcus aureus bacteraemia (SAB) occurs in Latin America. We conducted a prospective cohort study in 24 hospitals from nine Latin American countries.<h4>Objectives</h4>To assess the clinical impact of SAB in Latin America.<h4>Patients and methods</h4>We evaluated differences in the 30 day attributable mortality among patients with SAB due to MRSA compared with MSSA involving 84 days of follow-up. Adjusted r  ...[more]

Similar Datasets

| S-EPMC4447452 | biostudies-other
| S-EPMC4994353 | biostudies-literature
| S-EPMC8229717 | biostudies-literature
| S-EPMC8104220 | biostudies-literature
| S-EPMC6557488 | biostudies-literature